Background Obstruction of the aff erent or eff erent limbs of a gastrojejunal anastomosis is a potential complication aft er pancreaticoduodenectomy (PD) resulting in either gastric outlet obstruction or aff erent limb syndrome. Th e use of self-expanding metal stents for the management of anastomotic strictures aft er resection of pancreatic cancer has not been well studied. We present four such cases and review published data regarding this population.
Introduction
Obstruction of the aff erent or eff erent limbs of the gastrojejunal anastomosis is a recognized complication of pancreaticoduodenectomy (PD). Anastomotic obstruction results in either gastric outlet obstruction or aff erent limb syndrome. Immediate postoperative obstruction is usually related to a technical error or edema, while late obstruction may be the result of malignancy, adhesions, radiation induced strictures, or internal hernias. Traditionally, obstruction has been managed surgically or with balloon dilation [1, 2] . However, the development of self-expanding metal stents (SEMS) has provided a less invasive alternative. While studies have shown SEMS to be an eff ective treatment option in malignant gastric outlet obstruction [3] , the use of SEMS for anastomotic strictures aft er resection of pancreatic cancer has not been studied.
Methods
We report a case series of four patients who underwent enteral stenting of the aff erent or eff erent limb aft er PD for pancreatic cancer. Th e patients were identifi ed through an endoscopy database and retrospective chart review. Th is study was approved by our institutional review board.
Similar reported cases of aff erent or eff erent limb stenting aft er PD for pancreatic cancer were identifi ed through PubMed search using the terms: enteral stent, PD, pancreatic cancer, and gastric outlet obstruction. Th e results were summarized using descriptive statistics. A 75-year-old man underwent PD for T3N1 pancreatic adenocarcinoma with negative margins. He developed recurrent disease and eleven months following resection, he developed inability to tolerate solid foods. Computed tomography (CT) scan revealed a dilated stomach consistent with gastric outlet obstruction. Upper endoscopy demonstrated a tight angulation at the eff erent limb anastomosis (Fig. 1 ). An uncovered metal stent (27 mm × 60 mm, Evolution Duodenal Stent, Cook Medical, Bloomington, IN) was placed in the eff erent limb and the patient was subsequently able to resume a regular diet. Positron emission tomography CT scan demonstrated malignant recurrence surrounding the stent (Fig. 2) . Five weeks later, he developed recurrent vomiting. Repeat endoscopy revealed stent occlusion from tissue ingrowth and food debris. A second uncovered metal stent (22 mm × 90 mm, Boston Scientifi c WallFlex Duodenal Stent, Natick, MA) was placed within the existing stent with resolution of his symptoms. Four weeks later, the patient developed elevated total bilirubin 5.9 mg/dL, and alkaline phosphatase 488 U/L. An upper GI series demonstrated a patent eff erent limb without opacifi cation of the aff erent limb, consistent with aff erent limb syndrome. Esophagogastroduodenoscopy (EGD) revealed a strictured aff erent limb and an uncovered metal stent (22 mm × 90 mm, Evolution Duodenal Stent, Cook Medical, Bloomington, IN) was placed (Fig. 3) . Th e patient's bilirubin normalized aft er stent placement. Six weeks later, he developed bilious emesis. Endoscopic and fl uoroscopic evaluation revealed a narrowing of the distal eff erent limb stent followed by a 2 cm stricture immediately beyond the stent. A longer 22 mm × 120 mm stent (Evolution Duodenal Stent, Cook Medical, Bloomington, IN) was placed through the existing stents (Fig. 4) . Despite chemotherapy, the patient developed omental metastases and an enlarging porta hepatis mass. Th e patient passed away 3 weeks aft er stent placement.
Case 2
A 58-year-old woman underwent PD for T3N0 pancreatic adenocarcinoma with negative margins. She developed recurrent disease and 21 months postoperatively she developed abdominal pain, and fevers. Her labs revealed an elevated WBC count of 12,000, total bilirubin 3.0 mg/dL, and alkaline phosphatase 658 U/L. CT scan demonstrated dilation of proximal small bowel concerning aff erent limb obstruction, and blood cultures grew Escherichia coli. EGD revealed a strictured aff erent limb and a 22 mm × 90 mm metal duodenal stent (Boston Scientifi c WallFlex Duodenal Stent, Natick, MA) was placed across the stricture with immediate fl ow of bilious fl uid. Th e patient improved clinically and her bilirubinemia resolved. Ultimately, she developed progressive disease and died 6 months following stent placement. A 68-year-old woman with T3N1 pancreatic adenocarcinoma presented with progressive vomiting 10 months after PD with positive margins. An upper GI series showed a tight angulation at the efferent limb with minimal passage of contrast. Upper endoscopy was performed and 1000 mL of bilious fluid was aspirated from her stomach. The efferent limb was narrowed and a 22 mm × 90 mm metal stent (Boston Scientific WallFlex, Natick, MA) was deployed successfully. Shortly after deployment, the stent migrated into the stomach likely secondary to the acute angulation of the efferent limb. Repeat endoscopy was performed and a 22 mm × 90 mm uncovered metal stent with dual flares (Evolution Duodenal Stent, Cook Medical, Bloomington, IN) was placed with two hemoclips anchoring the intragastric portion of the stent to prevent migration. The stent remained in good position and the patient experienced symptomatic improvement. She subsequently demonstrated progressive disease with malignant ascites and expired 3 weeks later.
Case 4
A 47-year-old man underwent PD with negative margins for T3N1 pancreatic adenocarcinoma. Shortly thereaft er, he developed vomiting and upper GI series demonstrated delayed opacifi cation of the eff erent limb. Upper endoscopy revealed 400 mL of bilious fl uid in the stomach and an anastomotic stricture of the eff erent limb which extended 40 mm. A 22 mm x 60 mm uncovered metal stent (Evolution Duodenal Stent, Cook Medical, Bloomington, IN) was successfully placed allowing him to tolerate a regular diet. He later developed progressive ascites, peritoneal carcinomatosis with biliary dilation and died three months aft er stent placement.
Results
A literature search for cases of aff erent or eff erent limb obstruction aft er pancreatic surgery for pancreatic cancer treated with enteral stent identifi ed an additional 24 cases to our 4 cases. 16 patients underwent PD and 12 patients underwent palliative gastrojejunostomy. 24 patients received eff erent limb stents and 8 patients received aff erent limb stents (one patient received 2 stents and another from this case series received 4 stents). Th e etiology of obstruction was malignant in 26 of 27 patients. Stent placement was successful in 100% of cases and the rate of clinical improvement was 88% (22 of 25 patients). A variety of stents were utilized (Table 1) with the Wallstent (Boston Scientifi c, Natick, Massachusetts) as the most commonly utilized stent (8 patients). Th e median survival aft er enteral stent placement was 3.5 months.
Discussion
Late obstruction of the aff erent or eff erent limbs aft er PD for pancreatic cancer is oft en secondary to disease recurrence. Such obstruction impairs quality of life and generally represents a pre-terminal event. Less commonly, adhesions and radiation enteropathy may contribute. Palliative gastrojejunostomy in patients with pancreatic cancer is associated with a high 30-day mortality [4] and reoperation for anastomotic strictures likely carries a similarly high complication rate. A less invasive endoscopic approach is therefore attractive in a patient population with limited survival.
Review of published cases in the literature reveals that the etiology of anastomotic obstruction was malignant in 26 of 27 cases (Table 1) . Among our cases, malignant recurrence was not evident endoscopically. Instead, acute angulation at the stricture was the most common fi nding, seen in half of our cases. Despite the absence of endoscopic evidence of malignancy, all of our patients demonstrated evidence of disease recurrence on imaging either at the time of endoscopy or shortly aft er and none survived more than 6 months aft er stent placement. Th e median survival among pancreatic cancer patients with anastomotic strictures was 3.5 months.
Stenting of anastomotic strictures aft er PD or palliative gastrojejunostomy for pancreatic cancer was technically successful in all cases. Clinical improvement was observed in 88% of patients (22 of 25 cases), which is consistent with rates of improvement seen in other case series of stenting for malignant gastric outlet obstruction [5] . Obstruction of the eff erent limb was more common than aff erent limb obstruction (24 eff erent versus 8 aff erent limb stents). Enteral stent management of aff erent loop syndrome was successful in 5 of 6 cases. Th e single unsuccessful case was performed during early years of enteral stenting where the stent utilized was smaller in diameter than most enteral stents currently in use [6] .
It is technically feasible to concurrently place enteral stents in both the aff erent and eff erent limbs without compromising the patency of either stent. We report the second case of Figure 4 A metal stent in the aff erent limb and three metal stents in the eff erent limb in a patient with aff erent loop syndrome and recurrent malignant obstruction of the eff erent limb concurrent aff erent and eff erent stents aft er pancreatic cancer surgery [7] . Our patient required three eff erent limb stents for recurrent malignant obstruction along with an aff erent limb stent. Th is case also demonstrates that recurrent obstruction can be managed with progressively longer stents.
Few complications were reported in the literature. Th e main complication is stent migration. We reported one patient with proximal migration of the stent into the stomach. A subsequent attempt utilized two hemoclips to anchor a dual fl anged stent. Th ere was one reported case of stent migration into the terminal ileum in the only patient with a benign stricture [8] . Th ere were no cases of perforation, bleeding, or death. Potential complications of enteral stent placement include bleeding, tumor ingrowth/overgrowth, fi stulas, and obstruction [9] . Th ese complications can usually be managed endoscopically, oft en with placement of a second stent. We recommend uncovered, dual fl anged stents to minimize risk of stent migration. Shorter stents (40 or 60 mm) are preferable if the stricture is not long so as to reduce trauma to the contralateral wall.
In conclusion, the development of an anastomotic stricture aft er PD for pancreatic cancer is usually malignant and carries a poor prognosis. Palliation of both gastric outlet obstruction and aff erent limb syndrome can be provided with endoscopic placement of enteral stents. 
